Sector portfolio · VC firm · United States
Morningside Group's Biotech portfolio
Morningside Group has backed 31 Biotech startups in rounds we track, $2.2B between them, shown by the stage each has reached. The best-funded is Advancell.
31startups backed
4stages
$2.2Braised between them
Series Bbiggest stage
Morningside Group's whole portfolioMorningside Group's profile
Funding by segment
- Series B$415M9
- Series C and later$1.4B9
- Stage not reported$71M7
- Series A$302M6
Where they are based
- United States18$733M
- China7$510M
- United Kingdom2$252M
- Singapore1$39M
- Australia1$438M
- Switzerland1$194M
- France1$54M
United States
China
United Kingdom
Singapore
Australia
Switzerland
FranceFounded
9Earlier
12
513
214
115
16
417
18
219
220
121
122
23
24
25
26
4 without a founding year on record.
Total raised
- Under $1M1
- $1M to $10M4
- $10M to $50M13
- $50M to $250M11
- $250M to $1B2
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
27 of 31 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States18
- China7
- United Kingdom2
- Singapore1
- Australia1
- Switzerland1
- France1
Startups by country, 7 countries in all.
Segment by segment
Series B
9 startups · $415M raised
Nocion TherapeuticsNocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.United States$112M
CognoaCognoa is a pediatric behavioral health company founded in 2013, focused on developing digital diagnostics and therapeutics for chUnited States$85M
Epigenic TherapeuticsEpigenic Therapeutics is a biotechnology company based in China, founded in 2021.China$60M
DNAtriXDNAtrix is a clinical-stage biotechnology company based in Houston, Texas, with additional operations in San Diego, California.United States$40M
ASLAN PharmaceuticalsASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.Singapore$39M
Pinteon TherapeuticsPinteon is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of neurodegenerative diseases.United States$29M- XXgeneChina$20M
Senhwa BiosciencesSenhwa is a drug development company creating innovative therapies for cancer and related diseases.United States$17M
Series C and later
9 startups · $1.4B raised
AdvanCellAdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.Australia$438M- HBHeyuan BiotechnologyHeyuan Biotechnology is a biotechnology company focusing on the field of gene therapy services.China$300M
Alentis TherapeuticsAlentis Therapeutics is a clinical-stage biotechnology company based in Basel, Switzerland.Switzerland$194M- BBioVexTHOUSAND OAKS, Calif., March 4, 2011 /PRNewswire via COMTEX/ -- Amgen (Nasdaq: AMGN), today announced the completion of the acquisUnited Kingdom$133M
Green BiologicsGreen Biologics offers fermentation technologies for the conversion of biomass to renewable fuels and chemicals.United Kingdom$118M
MicuRx PharmaceuticalsMicuRx discovers and develops novel antimicrobials to treat drug-resistant infections and other diseases of significant unmet mediUnited States$90M- ABAccro BioscienceChina$64M
ENYO PharmaENYO Pharma is a clinical-stage biopharmaceutical company based in Lyon, France.France$54M
Stage not reported
7 startups · $71M raised
- ZZielBioZielBio is an early-stage biotechnology company that identifies novel high-value disease targets and develops therapeutic intervenUnited States$33M
InsilixaInSilixa is a private biotechnology and diagnostics company located in Sunnyvale, California.United States$13M
MedRhythmsMedrhythms utilizes sensors, music, and software to develop evidence-based, neurologic interventions to measure and improve walking.United States$9.6M
360Guanxi360Guanxi is an integrated media company that caters to Chinese chemical, pharmaceutical, and life science industries.China$5.0M
EndolytixEndolytix is a biotech company that develops therapeutic approaches that address intrinsic antibiotic resistance in NTM infections.United States$5.0M
EpiVaxEpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.United States$4.9M
VaxEquityVaxEquity is a biotechnology company that develops RNA therapeutics and vaccines.United States$870K
Series A
6 startups · $302M raised
AvrobioAvrobio is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.United States$85M
Adiso TherapeuticsAdiso Therapeutics develops medications to treat inflammatory diseases.United States$60M- MMobileMDChina$48M
Envisia TherapeuticsEnvisia Therapeutics is a biotechnology company based in Research Triangle Park, North Carolina, established in 2013 by Liquidia TUnited States$46M
Apic BioApic Bio, Inc.United States$40M
NeutrolisNeutrolis is a candidate-stage company advancing its first-in-class therapies that target Neutrophil Extracellular Traps (NETs).United States$23M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Morningside Group as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosSector portfolioMorningside Group's AI portfolio11 startups · $1.8BPortfolio mapMorningside Group portfolio map79 startups · $11BCo-investorsWho invests with Morningside Group39 co-investorsInvestments abroadMorningside Group's investments in China23 startups · $5.7BSector portfolioTechstars' AI portfolio336 startups · $4.9BSector portfolioAlumni Ventures' AI portfolio302 startups · $36B
Raising from investors like Morningside Group?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.